SCHEMBL9575434

SCHEMBL9575434

CC(=O)Nc1ncc2ncn(COC(COCc3ccccc3)COC(C)C)c2n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 3/20 0.37
CYP2D6 P10635 3/20 0.37
CYP2C9 P11712 3/20 0.37
CYP2C19 P33261 3/20 0.37
AGER Q15109 1/20 0.37
BRD4 O60885 1/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
ADRA1A P35348 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
TSHR P16473 2/20 0.33
GHSR Q92847 1/20 0.33
RPS6KA3 P51812 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
ACACB O00763 2/20 0.33
BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9575559 0.89 ALDH1A1 (0.41) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9019800 0.86 BCHE (0.38) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9575530 0.85 ACHE (0.43) BRD4TSHRHDAC6BCHEADORA2A
SCHEMBL9575793 0.85 ALDH1A1 (0.40) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9575441 0.84 RPS6KA3 (0.35) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9021161 0.80 BCHE (0.50) HPGDBCHEADORA2AACHE
SCHEMBL9845246 0.79 BCHE (0.36) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9575342 0.78 ACHE (0.43) BRD4TSHRHDAC6BCHEADORA2A
SCHEMBL9662815 0.77 ADORA2A (0.36) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9019831 0.77 BCHE (0.38) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5225550-A PROCESS FOR THE PREPARATION OF SUBSTITUTED ACYCLIC NUCLEOSIDES, AND INTERMEDIATES OCCURRING THEREIN HOECHST AKTIENGESELLSCHAFT (DE) 1993-07-06 US disclosed
EP-0464511-A2 Process for the preparation of acyclic, substituted nucleosides and its intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1992-01-08 EP disclosed